Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 5)

Link copied
Case Copied 10 min read

FEDERAL COURT OF AUSTRALIA

Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 5) [2012] FCA 112

Citation: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 5) [2012] FCA 112
Parties: SANOFI-AVENTIS AUSTRALIA PTY LTD ACN 008 558 807, SANOFI-AVENTIS DEUTSCHLAND GMBH and AVENTIS UB II INCORPORATED v APOTEX PTY LTD ACN 096 916 148
File number(s): NSD 1664 of 2008
Judge: JAGOT J
Date of judgment: 24 February 2012
Catchwords: COSTS – indemnity costs after 25 January 2011 – where Calderbank offer made by applicants – offer rejected by respondents – whether offer reasonable – whether applicants should pay respondent’s costs for the period since publication of the principal judgment on 29 July 2011 - where respondent had succeeded on disputed question of law - whether the applicants should pay the respondent’s costs of the motion to amend the patent
Cases cited: Calderbank v Calderbank [1976] Fam 93; [1975] 3 All ER 333
Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (2011) 92 IPR 320; [2011] FCA 846
Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 4) [2011] FCA 1307
Date of hearing: 16 February 2012
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 10
Counsel for the First, Second and Third Applicants: Mr C Dimitriadis
Solicitor for the First, Second and Third Applicants: Jones Day
Counsel for the Respondent: Mr DK Catterns QC with Mr NR Murray
Solicitor for the Respondent: Freehills

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 1664 of 2008

BETWEEN:

SANOFI-AVENTIS AUSTRALIA PTY LTD ACN 008 558 807
First Applicant

SANOFI-AVENTIS DEUTSCHLAND GMBH
Second Applicant

AVENTIS UB II INCORPORATED
Third Applicant

AND:

APOTEX PTY LTD ACN 096 916 148
Respondent

JUDGE:

JAGOT J

DATE OF ORDER:

24 FEBRUARY 2012

WHERE MADE:

SYDNEY

THE COURT ORDERS THAT:

1.Subject to order 2 below, the respondent pay the applicants’ costs of the proceedings as agreed or assessed save and except for the period between 29 July 2011 and 18 November 2011 in respect of which the respondent is to pay 80% of the applicants’ costs incurred within that period as agreed or assessed.

2.The applicants pay the respondent’s costs of the notice of motion dated 6 March 2009 as agreed or assessed.  

Note:Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 1664 of 2008

BETWEEN:

SANOFI-AVENTIS AUSTRALIA PTY LTD ACN 008 558 807
First Applicant

SANOFI-AVENTIS DEUTSCHLAND GMBH
Second Applicant

AVENTIS UB II INCORPORATED
Third Applicant

AND:

APOTEX PTY LTD ACN 096 916 148
Respondent

JUDGE:

JAGOT J

DATE:

24 FEBRUARY 2012

PLACE:

SYDNEY

REASONS FOR JUDGMENT

  1. The only issue remaining in this matter is costs. 

  2. The applicants (referred to as Sanofi-Aventis) seek orders that the respondent (referred to as Apotex) pay their costs on a party-party basis up to 25 January 2011 and on an indemnity basis thereafter.  Apotex seeks an order that…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 5) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2012] FCA 112
Decision Date

CaseChat Overview and Summary

In the case of Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 5), the applicants, Sanofi-Aventis, sought orders that the respondents, Apotex, pay their costs on a party-party basis up until 25 January 2011 and on an indemnity basis thereafter. Apotex, on the other hand, sought an order that it pay Sanofi-Aventis’s costs on a party-party basis until 29 July 2011, excluding the costs of Sanofi-Aventis’s notice of motion dated 6 March 2009, and orders that Sanofi-Aventis pay Apotex’s costs of that notice of motion and of the proceeding generally on and from 30 July 2011 on a party-party basis. The dispute centred around the resolution of the terms of the declarations and orders to be made in light of the conclusions in the earlier judgments in this case.

The legal issues before the court included whether the Calderbank offer made by Sanofi-Aventis was reasonable and whether Apotex should be liable for the costs of the notice of motion dated 6 March 2009. The court had to determine whether the applicants should pay the respondent’s costs for the period since publication of the principal judgment on 29 July 2011, given that the respondent had succeeded on a disputed question of law. The reasoning and outcome of the court's decision were based on the principles of indemnity costs following a rejected Calderbank offer and the specific circumstances of the motion for leave to amend the patent.

The court found that the Calderbank offer made by Sanofi-Aventis was reasonable and that Apotex unreasonably declined it. Consequently, Sanofi-Aventis was entitled to indemnity costs from 25 January 2011 onwards. However, the court also ruled that Apotex should not bear the costs of the notice of motion dated 6 March 2009, as Sanofi-Aventis should have borne those costs. Finally, the court ordered that Apotex pay Sanofi-Aventis’s costs of the proceedings on a party-party basis up until 25 January 2011 and 80% of the costs incurred by Sanofi-Aventis between 29 July 2011 and 18 November 2011 on an indemnity basis. Sanofi-Aventis, in turn, was ordered to pay Apotex’s costs of the notice of motion dated 6 March 2009.

Orders

Orders of the court

1. Subject to order 2 below, the respondent pay the applicants’ costs of the proceedings as agreed or assessed save and except for the period between 29 July 2011 and 18 November 2011 in respect of which the respondent is to pay 80% of the applicants’ costs incurred within that period as agreed or assessed.

2. The applicants pay the respondent’s costs of the notice of motion dated 6 March 2009 as agreed or assessed.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

The applicants (referred to as Sanofi-Aventis) seek orders that the respondent (referred to as Apotex) pay their costs on a party-party basis up to 25 January 2011 and on an indemnity basis thereafter. Apotex seeks an order that it pay Sanofi-Aventis’s costs on a party-party basis until 29 July 2011 excluding the costs of Sanofi-Aventis’s notice of motion dated 6 March 2009 and orders that Sanofi-Aventis pay Apotex’s costs of that notice of motion and of the proceeding generally on and from 30 July 2011 on a party-party basis.EARLIER JUDGMENTS There are two sets of reasons for judgment relevant to the resolution of the issue of costs. The first, the principal judgment, is Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (2011) 92 IPR 320; [2011] FCA 846. The second, a consequential judgment, is Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 4) [2011] FCA 1307. In the principal judgment Sanofi-Aventis succeeded in its case of threatened patent infringement and Apotex failed in its case of patent invalidity. In the consequential judgment I gave reasons for resolving the terms of the declarations and orders which should be made by reason of the conclusions in the principal judgment. The parties enjoyed mixed success and failure on their competing arguments. As a matter of impression, borne out by the reasons for judgment, the competing arguments involved one matter of real substance (described as the copyright issue) which had to be resolved in order to determine Sanofi-Aventis’s claim for an ongoing injunction in respect of the breaches of copyright which I had found in the principal judgment. Apotex succeeded on this issue. COMPETING POSITIONS OF THE PARTIES As Sanofi-Aventis succeeded in the principal judgment and obtained declarations and orders in its favour as set out in the consequential judgment it, unsurprisingly, claims that the usual order as to costs should apply to the whole of the matter (namely, that costs follow the event and thus Sanofi-Aventis has a prima facie entitlement to an order for costs in its favour for the whole matter). Sanofi-Aventis then claims that it should be awarded indemnity costs from 25 January 2011 onwards by reason of a Calderbank offer (Calderbank v Calderbank [1976] Fam 93; [1975] 3 All ER 333) to compromise the matter made on 17 January 2011 which Apotex, according to Sanofi-Aventis, unreasonably declined. Apotex claims that it should not be liable to pay Sanofi-Aventis’s costs of the notice of motion dated 6 March 2009 in which Sanofi-Aventis, with Apotex’s consent, sought leave of the court to amend the patent. As Apotex put it, irrespective of its consent, Sanofi-Aventis had to come to the court to obtain leave to amend and, in so doing, had to satisfy the court on evidence that such leave should be granted. Apotex contends it should not be liable for its costs in so doing. To the contrary, according to Apotex, Sanofi-Aventis should pay Apotex’s costs of that motion. Apotex also contends that it succeeded on the bulk of the issues dealt with in the consequential judgment, particularly the copyright issue, and thus should not be liable to pay Sanofi-Aventis’s costs after 30 July 2011 (the principal judgment having been delivered on 29 July 2011). Rather, according to Apotex, Sanofi-Aventis should pay Apotex’s costs on and from that date.DISCUSSION

Ratio Decidendi

Legal Principle Established